HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
Tax Provision
HUTCHMED (China) Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HUTCHMED (China) Ltd
LSE:HCM
|
Tax Provision
-$4.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-16%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Tax Provision
-HK$448.8m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-32%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Tax Provision
-¥643.3m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
0%
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Tax Provision
-¥797.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-11%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Tax Provision
¥171.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Tax Provision
-HK$2.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Tax Provision?
Tax Provision
-4.5m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Tax Provision amounts to -4.5m USD.
What is HUTCHMED (China) Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-16%
The average annual Tax Provision growth rates for HUTCHMED (China) Ltd have been 2% over the past three years , -3% over the past five years , and -16% over the past ten years .